BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhuang X, Hu X, Zhang S, Li X, Yuan X, Wu Y. Mesenchymal Stem Cell-Based Therapy as a New Approach for the Treatment of Systemic Sclerosis. Clin Rev Allergy Immunol 2022. [PMID: 35031958 DOI: 10.1007/s12016-021-08892-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Sadeghi B, Witkamp M, Schefberger D, Arbman A, Ringdén O. Immunomodulation by placenta-derived decidua stromal cells. Role of histocompatibility, accessory cells and freeze-thawing. Cytotherapy 2023;25:68-75. [PMID: 36333233 DOI: 10.1016/j.jcyt.2022.10.004] [Reference Citation Analysis]
2 Sun F, Sun Y, Wu F, Xu W, Qian H. Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Potential Therapy for Diabetes Mellitus and Diabetic Complications. Pharmaceutics 2022;14:2208. [DOI: 10.3390/pharmaceutics14102208] [Reference Citation Analysis]
3 Jiang Y, Hong S, Zhu X, Zhang L, Tang H, Jordan KL, Saadiq IM, Huang W, Lerman A, Eirin A, Lerman LO. IL-10 partly mediates the ability of MSC-derived extracellular vesicles to attenuate myocardial damage in experimental metabolic renovascular hypertension. Front Immunol 2022;13:940093. [DOI: 10.3389/fimmu.2022.940093] [Reference Citation Analysis]
4 Kuca-Warnawin E, Plebańczyk M, Ciechomska M, Olesińska M, Szczęsny P, Kontny E. Impact of Adipose-Derived Mesenchymal Stem Cells (ASCs) of Rheumatic Disease Patients on T Helper Cell Differentiation. Int J Mol Sci 2022;23:5317. [PMID: 35628127 DOI: 10.3390/ijms23105317] [Reference Citation Analysis]